Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice ...Middle East

Tennessee last year spent $48 million on a single drug, Humira — about $62,000 for each of the 775 patients who were covered by its employee health insurance program and receiving the treatment. So when nine Humira knockoffs, known as biosimilars, hit the market for as little as $995 a month, the opportunity for savings appeared ample and immediate. But it isn’t here yet. Makers of biosimilars must still work within a health care system in which basic economics rarely seems to hold sway. For real competition to take hold, the big pharmacy benefit managers, or PBMs, the companies that negotiate prices and set the prescription drug menu for 80% of insured patients in the Unite

Hence then, the article about save billions or stick with humira drug brokers steer americans to the costly choice was published today ( Tuesday 19/09/2023 - 12:01 PM ) and is available on KHN ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice )

Also on site :

• ‘Bachelor’ Alum Lauren Luyendyk Calls Out Alex Cooper Over Comments About Her Daughter: ‘Took It Too Far’
• 1991 Primetime Soap Finale Ranked Among 'Most Unforgettable' of All Time Aired Exactly 35 Years Ago Today
• Alternativa Film Festival Wraps in Medellín, Prizes ‘Runa Simi,’ ‘9-Month Contract,’ ‘A Useful Ghost’